The versatile heparin in COVID-19
- PMID: 32239799
- PMCID: PMC9906146
- DOI: 10.1111/jth.14821
The versatile heparin in COVID-19
Figures
Comment on
-
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27. J Thromb Haemost. 2020. PMID: 32220112 Free PMC article.
Similar articles
-
Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID-19 patients.J Thromb Haemost. 2020 Aug;18(8):2073-2075. doi: 10.1111/jth.14902. J Thromb Haemost. 2020. PMID: 32408391 Free PMC article. No abstract available.
-
Potential of heparin and nafamostat combination therapy for COVID-19.J Thromb Haemost. 2020 Jun;18(6):1521-1522. doi: 10.1111/jth.14858. Epub 2020 May 6. J Thromb Haemost. 2020. PMID: 32302456 Free PMC article. No abstract available.
-
Differentiating biochemical from clinical heparin resistance in COVID-19.J Thromb Thrombolysis. 2020 Nov;50(4):1015-1016. doi: 10.1007/s11239-020-02259-5. J Thromb Thrombolysis. 2020. PMID: 32880796 Free PMC article. No abstract available.
-
Heparin as a therapy for COVID-19: current evidence and future possibilities.Am J Physiol Lung Cell Mol Physiol. 2020 Aug 1;319(2):L211-L217. doi: 10.1152/ajplung.00199.2020. Epub 2020 Jun 10. Am J Physiol Lung Cell Mol Physiol. 2020. PMID: 32519894 Free PMC article. Review.
-
Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism.Semin Thromb Hemost. 2020 Oct;46(7):772-776. doi: 10.1055/s-0040-1710337. Epub 2020 May 11. Semin Thromb Hemost. 2020. PMID: 32392613 Free PMC article. Review. No abstract available.
Cited by
-
COVID-19-Associated Portal Vein Thrombosis Post-Cholecystitis.Int J Angiol. 2022 May 24;32(4):262-268. doi: 10.1055/s-0042-1743409. eCollection 2023 Dec. Int J Angiol. 2022. PMID: 37927847 Free PMC article.
-
COVID-19 Associated Micro-Anastomotic Thrombosis After Abdominal Free Tissue Transfer: A Case Report and Literature Review.Plast Surg (Oakv). 2023 Nov;31(4):408-412. doi: 10.1177/22925503231161081. Epub 2023 Mar 14. Plast Surg (Oakv). 2023. PMID: 37908324
-
Low-molecular-weight heparin for the prevention of clinical worsening in severe non-critically ill COVID-19 patients: a joint analysis of two randomized controlled trials.Intern Emerg Med. 2024 Jan;19(1):71-79. doi: 10.1007/s11739-023-03439-w. Epub 2023 Oct 4. Intern Emerg Med. 2024. PMID: 37794281 Clinical Trial.
-
Non-Anticoagulant Activities of Low Molecular Weight Heparins-A Review.Pharmaceuticals (Basel). 2023 Sep 5;16(9):1254. doi: 10.3390/ph16091254. Pharmaceuticals (Basel). 2023. PMID: 37765064 Free PMC article. Review.
-
Pathological Effects of SARS-CoV-2 Associated with Hematological Abnormalities.Curr Issues Mol Biol. 2023 Aug 28;45(9):7161-7182. doi: 10.3390/cimb45090453. Curr Issues Mol Biol. 2023. PMID: 37754237 Free PMC article. Review.
References
-
- Idell S. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med. 2003;31(4 Suppl):S213–S220. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
